WARREN C FISKUS to Imidazoles
This is a "connection" page, showing publications WARREN C FISKUS has written about Imidazoles.
Connection Strength
0.298
-
B-Raf Inhibition in the Clinic: Present and Future. Annu Rev Med. 2016; 67:29-43.
Score: 0.084
-
BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD. Mol Cancer Ther. 2014 Oct; 13(10):2315-27.
Score: 0.076
-
Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cells. Mol Cancer Ther. 2013 May; 12(5):577-88.
Score: 0.069
-
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer. Oncotarget. 2012 Nov; 3(11):1416-27.
Score: 0.068